STOCK TITAN

IOVANCE (NASDAQ: IOVA) CCO reports RSU vesting and tax share withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IOVANCE BIOTHERAPEUTICS, INC. Chief Commercial Officer Kirby Daniel Gordon reported routine equity compensation activity. On May 11, 2026, 10,000 restricted stock units (RSUs) vested and converted into common stock, with 2,435 shares withheld by the company to cover mandatory tax obligations rather than sold on the market.

After these transactions, Gordon directly holds 146,946 shares of common stock and 70,004 RSUs, which the filing states will vest in equal quarterly installments. The activity reflects compensation vesting and tax withholding, not open-market buying or selling.

Positive

  • None.

Negative

  • None.
Insider Kirby Daniel Gordon
Role Chief Commercial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 10,000 $0.00 --
Exercise Common Stock 10,000 $0.00 --
Tax Withholding Common Stock 2,435 $3.70 $9K
Holdings After Transaction: Restricted Stock Units — 70,004 shares (Direct, null); Common Stock — 149,381 shares (Direct, null)
Footnotes (1)
  1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person.
RSUs vested 10,000 RSUs Restricted stock units vested and converted to common stock on May 11, 2026
Shares withheld for taxes 2,435 shares Common stock withheld by issuer to satisfy mandatory tax withholding
Common stock held after 146,946 shares Directly held IOVANCE common stock after tax withholding disposition
RSUs remaining 70,004 RSUs Unvested restricted stock units remaining after vesting event
Exercise/Conversion price $0.00 per share RSUs convert to common stock with no exercise price
restricted stock units financial
"Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
mandatory tax withholding requirements financial
"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs."
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock."
equal quarterly installments financial
"The remaining RSUs will vest in equal quarterly installments."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kirby Daniel Gordon

(Last)(First)(Middle)
C/O IOVANCE BIOTHERAPEUTICS, INC.
825 INDUSTRIAL ROAD, SUITE 100

(Street)
SAN CARLOS CALIFORNIA 94070

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IOVANCE BIOTHERAPEUTICS, INC. [ IOVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026(1)M10,000A$0149,381D
Common Stock05/11/2026(2)F2,435D$3.7146,946(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(4)05/11/2026M10,000 (5) (5)Common Stock10,000$0.0070,004(6)D
Explanation of Responses:
1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
3. Represents the common stock remaining after deducting the common stock withheld for taxes.
4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
5. The remaining RSUs will vest in equal quarterly installments.
6. Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person.
/s/ Daniel Gordon Kirby05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did IOVANCE BIOTHERAPEUTICS (IOVA) report for Kirby Daniel Gordon?

IOVANCE reported that Chief Commercial Officer Kirby Daniel Gordon had 10,000 RSUs vest and convert into common stock. As part of this routine equity compensation event, some shares were withheld to satisfy mandatory tax obligations rather than sold on the open market.

Did Kirby Daniel Gordon sell IOVA shares in the latest Form 4 filing?

The filing shows no open-market sale of IOVA shares by Kirby Daniel Gordon. Instead, 2,435 shares were withheld by the company solely to satisfy mandatory tax withholding requirements tied to RSU vesting, which is a standard, non-discretionary compensation-related transaction.

How many IOVANCE (IOVA) shares and RSUs does Kirby Daniel Gordon hold after the transactions?

Following the reported transactions, Kirby Daniel Gordon directly holds 146,946 shares of IOVANCE common stock. He also holds 70,004 restricted stock units, which represent additional contingent rights to receive common shares according to the vesting schedule disclosed in the filing.

What happened to the 10,000 restricted stock units in the IOVANCE (IOVA) Form 4?

The 10,000 restricted stock units vested and converted into an equal number of IOVANCE common shares. A portion of these newly issued shares was withheld by the issuer to cover required tax liabilities, while the remainder increased Gordon’s directly held common stock position.

How will Kirby Daniel Gordon’s remaining IOVANCE (IOVA) RSUs vest over time?

The filing states that Gordon’s remaining 70,004 restricted stock units will vest in equal quarterly installments. Each RSU represents a contingent right to receive one share of IOVANCE common stock, so future vesting will gradually add to his share ownership, subject to conditions.

Is the tax-withholding disposition in the IOVANCE (IOVA) Form 4 a market signal?

The tax-withholding disposition is not treated as a market signal. Shares were withheld by the issuer to satisfy mandatory tax obligations triggered by RSU vesting, rather than sold in open-market transactions initiated for investment or portfolio management reasons.